Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Vizsgálati helyszín

Gentofte Hospital

Hellerup, DániaGentofte Hospital

29futó vizsgálat
21lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Még nem toboroz
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
NCT07441408· 3. fázis· Forrás
Toboroz
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
2025-525016-41-00· 2. fázis· Forrás
Toboroz
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
NCT07770841· 3. fázis· Forrás
Toboroz
Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
NCT06892210· 4. fázis· Forrás
Toboroz
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
NCT07339423· 3. fázis· Forrás
Toboroz
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
NCT07284459· 2. fázis· Forrás
Toboroz
The effect of colchicine, on insulin sensitivity in individuals with type 1 diabetes and systemic low-grade inflammation (INS1GHT)
2025-522528-29-00· 2. fázis· Forrás
Toboroz
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
NCT07267949· 2. fázis· Forrás
Toboroz
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
NCT07116967· 3. fázis· Forrás
Fut, nem toboroz
A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
NCT06934226· 3. fázis· Forrás
Fut, nem toboroz
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
NCT06858839· 3. fázis· Forrás
Fut, nem toboroz
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
NCT06780449· 3. fázis· Forrás
Még nem toboroz
Weight management with orismilast alone or in combination with s.c. semaglutide (WELOSITI)
2024-517463-23-00· 2. fázis· Forrás
Fut, nem toboroz
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622· 3. fázis· Forrás
Fut, nem toboroz
DAPHNE
2024-510746-14-00· 4. fázis· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
2023-503699-25-00· 3. fázis· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
2023-503697-21-01· 3. fázis· Forrás
Toboroz
Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
NCT06401616· 4. fázis· Forrás
Fut, nem toboroz
The Colchicine heart failure preserved trial
2023-506207-26-00· 3. fázis· Forrás
Fut, nem toboroz
Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controlled, investigator-initiated trial
2022-502038-23-00· 2. fázis· Forrás
Fut, nem toboroz
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769· 3. fázis· Forrás
Toboroz
The Colchicine and atrial fibrillation trial
2022-500850-40-01· 3. fázis· Forrás
Fut, nem toboroz
HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation.
NCT05636176· 3. fázis· Forrás
Toboroz
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
NCT05633810· 3. fázis· Forrás
Toboroz
Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms
NCT05028153· 2. fázis· Forrás
Még nem toboroz
A 6-Month, Randomized, Double-Blind Study to Evaluate the Effect of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease (DECODE-CKD)
2024-517040-65-02· 1/2. fázis· Forrás
Toboroz
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NCT03563417· Forrás
Fut, nem toboroz
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF
NCT02755441· Forrás
Fut, nem toboroz
Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay
NCT02772549· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Idiopátiás tüdőfibrózis3 toboroz
Pitvarfibrilláció3 toboroz
Elhízás2 toboroz
1-es típusú cukorbetegség1 toboroz
2-es típusú cukorbetegség1 toboroz
Asztma1 toboroz
Koszorúér-betegség1 toboroz
Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
Krónikus vesebetegség1 toboroz
Pikkelysömör1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Lezárult
The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes
NCT07373236· Forrás
Lezárult
The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 Diabetes
NCT06881472· Forrás
Lezárult
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)
2023-506185-31-00· 2/3. fázis· Forrás
Fut, nem toboroz
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
2023-508235-31-00· 3. fázis· Forrás
Lezárult
A proof of concept and dose-finding study of XXB750 in patients with heart failure
2023-504678-39-00· 2. fázis· Forrás
Lezárult
Using live vaccines to induce beneficial innate immune training and reduce systemic inflammation in COPD patients
2023-504519-34-01· 2. fázis· Forrás
Leállították
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
NCT06097260· 2. fázis· Forrás
Lezárult
A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)
NCT05882877· 3. fázis· Forrás
Fut, nem toboroz
Dapiglutide for the Treatment of Obesity
NCT05788601· 2. fázis· Forrás
Lezárult
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon)
2022-501538-44-00· 3. fázis· Forrás
Lezárult
A Study For Treatment Of Paroxysmal Atrial Fibrillation (PAF) With The THERMOCOOL SMARTTOUCH SF Catheter and TRUPULSE Generator
NCT05752487· Forrás
Lezárult
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
NCT05651711· 3. fázis· Forrás
Lezárult
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke
NCT05643573· 3. fázis· Forrás
Fut, nem toboroz
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
NCT05567796· 3. fázis· Forrás
Lezárult
Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT05255991· 3. fázis· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2023-507093-40-00· 2. fázis· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
NCT05037929· 2. fázis· Forrás
Lezárult
Eosinophil-guided Reduction of Inhaled Corticosteroids
NCT04481555· 4. fázis· Forrás
Lezárult
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293· 3. fázis· Forrás
Lezárult
DANHEART (H-HeFT and Met-HeFT)
NCT03514108· 4. fázis· Forrás
Lezárult
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
NCT01938248· 4. fázis· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 12.